
南美洲输血诊断市场预测至 2028 年 - COVID-19 影响和按产品(仪器、试剂盒和试剂)、应用(血型和疾病筛查)和最终用户(医院、诊断实验室、血库和血浆)进行的区域分析分馏公司)
No. of Pages: 124 | Report Code: BMIRE00027405 | Category: Life Sciences
No. of Pages: 124 | Report Code: BMIRE00027405 | Category: Life Sciences
输血诊断技术发展
输血诊断通常在肾移植等长时间手术和紧急情况下进行。这些手术可能会导致失血过多,因此很难用新鲜血液来弥补失血,尤其是在稀有血型的情况下。由于需求充足,输血诊断市场的主要参与者提供先进的全自动输血诊断,以减少人为干预。例如,2019 年 4 月,BD 推出了 BD BACTEC 质量控制介质,以帮助识别输血过程中受污染的血小板单位。此外,许多公司还采取战略活动,例如收购、合作和其他活动来占领市场。例如,2019 年 12 月,Getinge 收购了 Applikon Biotechnology,该公司是开发和供应从实验室到工业规模的创新生物反应器系统的领导者。 2019 年 10 月,美敦力收购 AV Medical Technologies。因此,这些进步可能会在未来几年为输血诊断市场带来新趋势。
市场概述
巴西是 SAM 中最大的国家之一。它拥有完善的医疗器械行业,并受巴西国家卫生监督局(ANVISA)监管。同样,国家计量标准化和工业质量研究所 (INMETRO) 为该国医疗器械行业的公司制定标准和指南。巴西拥有该地区最重要的医疗设备产业,也是美国最大的医疗设备进口国,约 30% 的医疗设备从美国进口。此外,脓毒症在巴西是一个严重的健康问题,这种情况需要输血作为治疗方法。 2022年巴西SciELO发表的一项研究表明,巴西ICU脓毒症患病率为30%,而ICU患者的医院死亡率为55%。脓毒症造成重大负担的原因包括清洁水、卫生设施和营养不足;疫苗接种不足;获得重症监护服务的机会较少;医疗保健相关感染的发生率增加。因此,脓毒症患病率的不断上升是促进巴西输血诊断市场增长的因素之一。此外,根据巴西卫生部的数据,1.9%的巴西人口每年献血,约400万次献血。在巴西,每年采集约 300 万单位血液,公共系统约占这些地区捐献的 70%。因此,上述因素推动了巴西对输血诊断的需求。
SAM 输血诊断市场细分
SAM 输血诊断市场根据产品、应用、最终用户和国家进行细分。
雅培; BAG 诊断有限公司; Bio-Rad 实验室公司; DiaSorin SpA; F.霍夫曼-拉罗氏有限公司;南澳州格里福斯; Immucor 有限公司; Ortho 临床诊断(QuidelOrtho 公司);商数有限;和 Thermo Fisher Scientific Inc. 是 SAM 输血诊断市场的领先公司。
Strategic insights for South America Blood Transfusion Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 217.55 Million |
Market Size by 2028 | US$ 302.89 Million |
Global CAGR (2022 - 2028) | 5.7% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South America Blood Transfusion Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South America Blood Transfusion Diagnostics Market is valued at US$ 217.55 Million in 2022, it is projected to reach US$ 302.89 Million by 2028.
As per our report South America Blood Transfusion Diagnostics Market, the market size is valued at US$ 217.55 Million in 2022, projecting it to reach US$ 302.89 Million by 2028. This translates to a CAGR of approximately 5.7% during the forecast period.
The South America Blood Transfusion Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Blood Transfusion Diagnostics Market report:
The South America Blood Transfusion Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Blood Transfusion Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Blood Transfusion Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.